Brief: Clinuvel Pharmaceuticals Says Qtrly Receipts From Customers A$25.5 Million
31/10/2022 01:31
Oct 31 (Reuters) - Clinuvel Pharmaceuticals Ltd
CUV.AX :
* QTRLY RECEIPTS FROM CUSTOMERS A$25.5 MILLION
Further company coverage: CUV.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clinuvel Pharmaceuticals
See all newsBrief: Clinuvel Pharmaceuticals Announces Strategic Reorganisation To Refocus On U.S. Markets
Brief: Clinuvel Pharmaceuticals Ltd's ADS To Commence Trading On Nasdaq
Brief: Clinuvel Pharmaceuticals Says Scenesse Approved For EPP In Canada
Australia's Clinuvel Pharmaceuticals rises on Canada nod for phototoxicity prevention drug
Brief: Clinuvel Pharmaceuticals Updates On Level II ADR Upgrade, Nasdaq Uplist